Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers-Reference-Cited by-同舟云学术

Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers

Published:2019-08-28 Issue:1 Volume:39 Page:50-63
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Sun Bowen,Mason Seth,Wilson Robert C.,Hazard Starr E.^ORCID,Wang Yubao,Fang Rong,Wang Qiwei,Yeh Elizabeth S.,Yang Meixiang,Roberts Thomas M.,Zhao Jean J.,Wang Qi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0953-9.pdf

Reference52 articles.

1. Stuhlmiller T, Earp H, Johnson G. Adaptive reprogramming of the breast cancer kinome. Clin Pharmacol Ther. 2014;95:413–5.

2. Stuhlmiller TJ, Miller SM, Zawistowski JS, Nakamura K, Beltran AS, Duncan JS, et al. Inhibition of lapatinib-induced kinome reprogramming in ERBB2-positive breast cancer by targeting BET family bromodomains. Cell Rep. 2015;11:390–404.

3. Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5:341–54.

4. Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, et al. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer cell. 2007;12:395–402.

5. Moasser MM, Krop IE. The evolving landscape of HER2 targeting in breast cancer. JAMA Oncol. 2015;1:1154–61.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer;Life Sciences;2024-09

2. Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer;Anti-Cancer Drugs;2024-08-21

3. From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond;Pharmaceutics;2024-07-01

4. Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers;Oncogene;2024-05-29

5. Advances in breast cancer research using CRISPR/Cas9 system;Nano Select;2024-05-26